Cargando…
The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions
BACKGROUND: The burden of advanced non-small cell lung cancer (NSCLC) is not well understood, and the number of patients likely to receive treatment in Europe has not been quantified. The aim of this study was to forecast the annual number of patients with squamous and non-squamous advanced NSCLC li...
Autores principales: | Campbell, David, O’Day, Ken, Hertel, Nadine, Penrod, John R., Manley Daumont, Melinda, Lees, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257974/ https://www.ncbi.nlm.nih.gov/pubmed/30477516 http://dx.doi.org/10.1186/s12963-018-0174-4 |
Ejemplares similares
-
Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2013) -
Costs and Cost Drivers Associated with Non-Small-Cell Lung Cancer Patients Who Received Two or More Lines of Therapy in Europe
por: Verleger, Katharina, et al.
Publicado: (2020) -
Modelling the initial epidemic trends of COVID-19 in Italy, Spain, Germany, and France
por: Wang, Kai, et al.
Publicado: (2020) -
The Asylums of Italy, France, and Germany
por: Arlidge, J. T.
Publicado: (1859) -
Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness study
por: Darbà, Josep, et al.
Publicado: (2015)